These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33513422)

  • 41. Urate testing in gout: why, when and how.
    Dalbeth N; Winnard D; Gow PJ; Boswell DR; Te Karu L; Lindsay K; Arroll B; Stamp LK
    N Z Med J; 2015 Aug; 128(1420):65-8. PubMed ID: 26367514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A stable liver-specific urate oxidase gene knockout hyperuricemia mouse model finds activated hepatic de novo purine biosynthesis and urate nephropathy.
    Pang L; Liang N; Li C; Merriman TR; Zhang H; Yan F; Sun W; Li R; Xue X; Liu Z; Wang C; Cheng X; Chen S; Yin H; Dalbeth N; Yuan X
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167009. PubMed ID: 38237409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Rasburicase therapy may cause hydrogen peroxide shock].
    Góth L
    Orv Hetil; 2008 Aug; 149(34):1587-90. PubMed ID: 18708312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Resurrected" human-source urate oxidase with high uricolytic activity and stability.
    Jiang N; Xu C; Zhang L; Chen J
    Enzyme Microb Technol; 2021 Sep; 149():109852. PubMed ID: 34311889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pegloticase (krystexxa) for treatment of refractory gout.
    Med Lett Drugs Ther; 2011 Feb; 53(1357):9-10. PubMed ID: 21304442
    [No Abstract]   [Full Text] [Related]  

  • 46. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.
    Terkeltaub R; Bushinsky DA; Becker MA
    Arthritis Res Ther; 2006; 8 Suppl 1(Suppl 1):S4. PubMed ID: 16820043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The identification of an integral membrane, cytochrome c urate oxidase completes the catalytic repertoire of a therapeutic enzyme.
    Doniselli N; Monzeglio E; Dal Palù A; Merli A; Percudani R
    Sci Rep; 2015 Sep; 5():13798. PubMed ID: 26349049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacist-managed titration of urate-lowering therapy to streamline gout management.
    Huang IJ; Liew JW; Morcos MB; Zuo S; Crawford C; Bays AM
    Rheumatol Int; 2019 Sep; 39(9):1637-1641. PubMed ID: 31147732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S35-43. PubMed ID: 21654268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An association of smoking with serum urate and gout: A health paradox.
    Fanning N; Merriman TR; Dalbeth N; Stamp LK
    Semin Arthritis Rheum; 2018 Jun; 47(6):825-842. PubMed ID: 29398126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of GLUT12/SLC2A12 as a urate transporter that regulates the blood urate level in hyperuricemia model mice.
    Toyoda Y; Takada T; Miyata H; Matsuo H; Kassai H; Nakao K; Nakatochi M; Kawamura Y; Shimizu S; Shinomiya N; Ichida K; Hosoyamada M; Aiba A; Suzuki H
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18175-18177. PubMed ID: 32690690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of urate-lowering therapy in hyperuricemia patients: a systematic review and Bayesian network meta-analysis of randomized controlled trials.
    Lin YJ; Lin SY; Lin CH; Wang ST; Chang SS
    Clin Rheumatol; 2020 May; 39(5):1633-1648. PubMed ID: 31965378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New therapeutic approach to hyperuricemia and gout in the light of recommendations.
    Lioté F
    Joint Bone Spine; 2016 Jul; 83(4):376-80. PubMed ID: 27085801
    [No Abstract]   [Full Text] [Related]  

  • 56. Management of hyperuricemia with rasburicase review.
    de Bont JM; Pieters R
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1431-40. PubMed ID: 15571272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study.
    Hosoya T; Sano T; Sasaki T; Fushimi M; Ohashi T
    Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):53-61. PubMed ID: 31792640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiologic and biochemical basis for the treatment of gout and hyperuricemia.
    Mikkelsen WM; Robinson WD
    Med Clin North Am; 1969 Nov; 53(6):1331-47. PubMed ID: 4900718
    [No Abstract]   [Full Text] [Related]  

  • 59. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
    Ganson NJ; Kelly SJ; Scarlett E; Sundy JS; Hershfield MS
    Arthritis Res Ther; 2006; 8(1):R12. PubMed ID: 16356199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pegloticase for treating refractory chronic gout.
    George RL; Sundy JS
    Drugs Today (Barc); 2012 Jul; 48(7):441-9. PubMed ID: 22844655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.